(4aS,6aS,6bR,8aR,13aR,13bR,15bS)-2,2,6a,6b,9,9,13a-heptamethyl-11-(piperidin-3-yl)-1,2,3,4,5,6,6a,6b,7,8,8a,9,11,13,13a,13b,14,15b-octadecahydro-4aH-chryseno[1,2-f]indazole-4a-carboxylic acid hydrochloride

ID: ALA5277425

Max Phase: Preclinical

Molecular Formula: C36H56ClN3O2

Molecular Weight: 561.86

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)Cc6cn(C7CCCNC7)nc6C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1.Cl

Standard InChI:  InChI=1S/C36H55N3O2.ClH/c1-31(2)14-16-36(30(40)41)17-15-34(6)25(26(36)20-31)10-11-28-33(5)19-23-22-39(24-9-8-18-37-21-24)38-29(23)32(3,4)27(33)12-13-35(28,34)7;/h10,22,24,26-28,37H,8-9,11-21H2,1-7H3,(H,40,41);1H/t24?,26-,27-,28+,33-,34+,35+,36-;/m0./s1

Standard InChI Key:  MQXPWAVNRXRZJI-AFTMAHIYSA-N

Molfile:  

     RDKit          2D

 45 50  0  0  0  0  0  0  0  0999 V2000
    3.3705   -2.2098    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.2424   -0.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5248   -0.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8073   -0.4112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0898   -0.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0898   -1.6574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6276   -2.0686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3451   -1.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3451   -0.8224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6233   -0.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1352   -0.5656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6235   -1.2377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1352   -1.9099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4545   -1.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2248   -2.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0556   -2.7860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8073   -2.0728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5248   -1.6574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0898   -2.4840    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0898    0.0084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8073    0.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5290    0.8392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2424    0.4112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9641    0.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6816    0.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4075    0.8224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4075    1.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6899    2.0686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9641    1.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2662    2.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0970    2.7902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6816   -0.4238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9599   -0.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3992   -0.0041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3992   -0.8392    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1165    0.4112    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9641    0.0041    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.8073   -1.2420    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.5248    0.0084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2424   -1.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8700   -1.9574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7009   -1.9574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1165   -1.2377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7009   -0.5180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8701   -0.5180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  5  6  1  0
  7  6  1  0
  8  7  1  0
  9  8  1  0
  9 10  1  0
 10  5  1  0
  9 11  2  0
 12 11  1  0
 13 12  1  0
  8 13  2  0
 12 14  1  0
 15  7  1  0
 16  7  1  0
  6 17  1  0
 17 18  1  0
 18  3  1  0
  6 19  1  6
  5 20  1  1
 21  4  1  0
 22 21  1  0
 22 23  2  0
 23  2  1  0
 24 23  1  0
 24 25  1  0
 26 25  1  0
 27 26  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
 30 28  1  0
 31 28  1  0
 25 32  1  0
 32 33  1  0
 33  2  1  0
 25 34  1  1
 35 34  2  0
 36 34  1  0
 24 37  1  1
  4 38  1  6
  3 39  1  1
  2 40  1  6
 41 14  1  0
 42 41  1  0
 43 42  1  0
 44 43  1  0
 45 44  1  0
 14 45  1  0
M  END

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Macrophage (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 561.86Molecular Weight (Monoisotopic): 561.4294AlogP: 7.71#Rotatable Bonds: 2
Polar Surface Area: 67.15Molecular Species: ZWITTERIONHBA: 4HBD: 2
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.42CX Basic pKa: 9.74CX LogP: 5.03CX LogD: 5.03
Aromatic Rings: 1Heavy Atoms: 41QED Weighted: 0.36Np Likeness Score: 2.18

References

1. Yu Y, Yuan W, Yuan J, Wei W, He Q, Zhang X, He S, Yang C..  (2023)  Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation.,  80  [PMID:36701870] [10.1016/j.bmc.2023.117177]

Source